Search

Author/Creator Thanigaimani, Pradeep

1. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. (March 2022)

Authors:
Marron, Thomas U; Fiel, Maria Isabel; Hamon, Pauline; Fiaschi, Nathalie; Kim, Edward; Ward, Stephen C; Zhao, Zhen; Kim, Joel; Kennedy, Paul; Gunasekaran, Ganesh; Tabrizian, Parissa; Doroshow, Deborah; Legg, Meredith; Hammad, Ashley; Magen, Assaf; Kamphorst, Alice O; Shareef, Muhammed; Gupta, Nami...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 3(2022)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study. (November 2018)

Authors:
Cohen, Roger B.; Delord, Jean-Pierre; Doi, Toshihiko; Piha-Paul, Sarina A.; Liu, Stephen V.; Gilbert, Jill; Algazi, Alain P.; Damian, Silvia; Hong, Ruey-Long; Le Tourneau, Christophe; Day, Daphne; Varga, Andrea; Elez, Elena; Wallmark, John; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan; ...
Journal:
American journal of clinical oncology
Issue:
Volume 41:Number 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗